8-KAccepted Oct 22, 5:09 PM ET
Intuitive Machines: director resignation and appointment
Accepted (ET)
5:09 PM
Oct 22, 2026
Filed
Oct 22, 2026
Documents
12
Size
155.0 KB
Summary
Intuitive Machines: director resignation and appointment
What happened The filing says that Michael Blitzer resigned from the Board of Directors on Oct 21, 2026, including from the Nominating and Corporate Governance Committee, Conflict Committee and Audit Committee and as Chair of the Compensation Committee, effective immediately. The filing says the resignation was not the result of any disagreement with the company on any matter relating to the company’s operations, policies or practices.
The filing says that on Oct 22, 2026 the Board appointed Dr. Christopher Scolese as a Class II director, effective Oct 22, 2026, to serve for an initial term expiring at the company’s annual meeting of stockholders to be held in 2027 and until his successor is duly elected and qualified or until his earlier death, resignation, disqualification or removal. The filing says Dr. Scolese was appointed to serve as a member of the Audit Committee and the Nominating and Corporate Governance Committee and as Chair of the Conflicts Committee.
Key details
- Michael Blitzer resigned effective Oct 21, 2026; filing states resignation was not due to any disagreement with the company on operations, policies or practices.
- Dr. Christopher Scolese was appointed Oct 22, 2026 as a Class II director, with an initial term expiring at the 2027 annual meeting.
- Dr. Scolese was appointed to the Audit Committee, the Nominating and Corporate Governance Committee and as Chair of the Conflicts Committee.
- The filing says Dr. Scolese is eligible to participate in the company’s Non-Employee Director Compensation Program (as described in the definitive proxy filed Apr 24, 2026) and that the company expects to enter into its standard form of indemnification agreement with him.
Why it may matter This report was made under Item 5.02 (departure of directors or certain officers; election of directors), which covers changes in board membership and committee assignments. The filing does not show why the insider traded or why the company acted.